HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AB&B BIO-TECH-B

29.320

0.000

Volume:- -

Turnover:- -

Market Cap:11.52B

PE:-34.96

High:29.320

Open:29.320

Low:29.320

Close:29.320

52wk High:73.000

52wk Low:28.880

Shares:393.00M

HK Float Shares:296.36M

Volume Ratio:0.51

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:--

ROA:--

PB:293.39

PE(LYR):-34.96

PS:30.50

Loading ...

Overview Company News Filings

AB&B Bio-Tech-B Maintains Stable Share Capital in June; Public Float Remains Compliant

Bulletin Express

AB&B Bio-Tech releases quarterly resumption update, defers 2025 AGM; trading to stay suspended

Bulletin Express

Hong Kong Market Announcement Highlights: Seer Tech and Micot Pharma Debut Today, Cathay Pacific Reports 17% Passenger Growth in May

Ab&B Bio-Tech's Application for Mpox Vaccine Approved in China

MT Newswires Live

AB&B BIO-TECH-B's mRNA Monkeypox Vaccine Candidate Receives IND Approval from China's CDE

AB&B Bio-Tech wins China CDE IND clearance for mRNA mpox vaccine candidate

Ab&B Bio Tech Co Js - China Cde Approves Ind Application for Mrna Mpox Vaccine on June 21, 2026

THOMSON REUTERS

AB&B Bio-Tech appoints Baker Tilly Aranea and Cheng & Cheng for forensic investigation and internal control review; trading remains suspended

Bulletin Express

AB&B Bio-Tech hires Baker Tilly unit for forensic probe into fund investments, consultancy payments

AB&B Bio-Tech Reports No Change in Share Capital for May 2026; Confirms Public Float Compliance

Bulletin Express

Ab&B Bio-Tech Updates Board Composition and Committee Assignments

Bulletin Express

AB&B Bio-Tech files directors list with Hong Kong stock exchange

AB&B BIO-TECH-B (02627) Appoints Le Meijia as Independent Non-Executive Director

AB&B BIO-TECH-B (02627) Commences Phase I/II Trials for Its Adjuvanted RSV Vaccine

AB&B Bio-Tech wins China NMPA approval for RSV vaccine clinical trial program

AB&B Bio-Tech starts Phase I/II trials for self-developed recombinant RSV vaccine candidate

Ab&B Bio-Tech obtains China CDE IND approval for mRNA RSV vaccine candidate

Bulletin Express

AB&B BIO-TECH-B Receives Chinese Regulatory Nod for mRNA RSV Vaccine Clinical Trial Application

AB&B Bio-Tech wins China CDE IND approval for self-developed mRNA RSV vaccine

Ab&B Bio Tech Co Ltd Js - China Cde Approves Ind Application for Ab+B Bio-Tech's Mrna Rsv Vaccine Candidate

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/02627/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"AB&B BIO-TECH-B","latestPrice":29.32,"timestamp":1787275207144,"preClose":29.32,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":296361845,"shares":393000000,"eps":-0.8385895589238526,"marketStatus":"Halted","change":0,"latestTime":"08-21 09:20:07","open":29.32,"high":29.32,"low":29.32,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.7293047071646448,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":29.32,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.5100838100119135,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.83859,"volumeRatio":0.5100838100119135,"shares":393000000,"dividePrice":0,"high":29.32,"amplitude":0,"preClose":29.32,"low":29.32,"week52Low":28.88,"pbRate":"293.39","psRate":"30.50","week52High":73,"institutionHeld":0,"latestPrice":29.32,"eps":-0.8385895589238526,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.7293047071646448,"open":29.32,"prevYearClose":40.24,"prevWeekClose":29.32,"prevMonthClose":29.32,"prevQuarterClose":29.32,"fiveDayClose":29.32,"twentyDayClose":29.32,"sixtyDayClose":29.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null},{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2026-08-21","current":-40.202675,"percent":0.988142,"low":-109.844469,"twenty":-74.600848,"median":-63.899985,"eighty":-44.518459,"high":-18.07815,"avg":-59.988502,"sd":14.538107,"marketCap":11535737032},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900},{"date":"2025-08-29","current":-64.920623,"twenty":-66.830053,"median":-65.395346,"eighty":-57.22288,"marketCap":20065572600},{"date":"2025-09-05","current":-62.716917,"twenty":-66.416243,"median":-63.912829,"eighty":-60.155426,"marketCap":19365244772},{"date":"2025-09-12","current":-62.655098,"twenty":-66.251138,"median":-63.08644,"eighty":-59.27469,"marketCap":19380982476},{"date":"2025-09-19","current":-81.048551,"twenty":-68.315951,"median":-63.912829,"eighty":-59.882299,"marketCap":19888523430},{"date":"2025-09-26","current":-77.095946,"twenty":-77.153546,"median":-65.395346,"eighty":-60.155426,"marketCap":18869507096},{"date":"2025-10-03","current":-76.784092,"twenty":-77.86406,"median":-66.074095,"eighty":-61.128611,"marketCap":18838031688},{"date":"2025-10-10","current":-75.450727,"twenty":-78.338288,"median":-66.623148,"eighty":-61.710077,"marketCap":18483933348},{"date":"2025-10-17","current":-70.044793,"twenty":-77.841467,"median":-68.315951,"eighty":-62.332762,"marketCap":17146228508},{"date":"2025-10-24","current":-70.694139,"twenty":-77.356453,"median":-69.86748,"eighty":-62.632094,"marketCap":17311474400},{"date":"2025-10-31","current":-64.652972,"twenty":-77.130506,"median":-68.586563,"eighty":-62.679826,"marketCap":15855736780},{"date":"2025-11-07","current":-65.014442,"twenty":-77.0495,"median":-67.012733,"eighty":-63.012535,"marketCap":15934425300},{"date":"2025-11-14","current":-69.152784,"twenty":-76.901535,"median":-66.692171,"eighty":-63.572329,"marketCap":16996720320},{"date":"2025-11-21","current":-64.47659,"twenty":-76.671062,"median":-66.251138,"eighty":-63.813259,"marketCap":15839999076},{"date":"2025-11-28","current":-66.221916,"twenty":-76.081201,"median":-65.883561,"eighty":-63.948664,"marketCap":16327867900},{"date":"2025-12-05","current":-64.387851,"twenty":-75.140133,"median":-65.711289,"eighty":-64.052768,"marketCap":15902949892},{"date":"2025-12-12","current":-65.09579,"twenty":-74.230454,"median":-65.51992,"eighty":-64.060512,"marketCap":16107540044},{"date":"2025-12-19","current":-64.75238,"twenty":-73.314016,"median":-65.09579,"eighty":-64.128623,"marketCap":16060326932},{"date":"2025-12-24","current":-63.88714,"twenty":-72.937878,"median":-65.019631,"eighty":-64.128296,"marketCap":15895081040},{"date":"2026-01-02","current":-63.38466,"twenty":-72.68164,"median":-64.955716,"eighty":-63.907691,"marketCap":15832130224},{"date":"2026-01-09","current":-64.42138,"twenty":-72.421694,"median":-64.920623,"eighty":-63.984499,"marketCap":16131146600},{"date":"2026-01-16","current":-79.012958,"twenty":-72.68164,"median":-65.002626,"eighty":-63.984499,"marketCap":19849179170},{"date":"2026-01-23","current":-80.264585,"twenty":-74.684429,"median":-65.09579,"eighty":-64.012742,"marketCap":20144261120},{"date":"2026-01-30","current":-75.685884,"twenty":-76.499114,"median":-65.441715,"eighty":-64.034272,"marketCap":19081966100},{"date":"2026-02-06","current":-72.661412,"twenty":-75.84841,"median":-65.678772,"eighty":-64.110439,"marketCap":18365900568},{"date":"2026-02-13","current":-79.706332,"twenty":-76.558032,"median":-65.817553,"eighty":-64.12895,"marketCap":20262293900},{"date":"2026-02-20","current":-82.611175,"twenty":-76.790716,"median":-65.857422,"eighty":-64.132361,"marketCap":20970490580},{"date":"2026-02-27","current":-82.941496,"twenty":-77.55936,"median":-66.221916,"eighty":-64.146544,"marketCap":21285244660},{"date":"2026-03-06","current":-81.374491,"twenty":-78.249638,"median":-66.33369,"eighty":-64.163416,"marketCap":20714752890},{"date":"2026-03-13","current":-88.155391,"twenty":-78.824484,"median":-66.830053,"eighty":-64.221195,"marketCap":22544260980},{"date":"2026-03-20","current":-60.352659,"twenty":-78.705126,"median":-66.485266,"eighty":-64.132361,"marketCap":15375736808},{"date":"2026-03-27","current":-47.779776,"twenty":-78.691316,"median":-66.244034,"eighty":-64.004997,"marketCap":12141638636},{"date":"2026-04-02","current":-45.178314,"twenty":-78.677046,"median":-65.897052,"eighty":-63.746879,"marketCap":11535737032},{"date":"2026-04-10","current":-44.832534,"twenty":-78.441179,"median":-65.857422,"eighty":-63.430885,"marketCap":11535737032},{"date":"2026-04-17","current":-44.813717,"twenty":-78.181043,"median":-65.711289,"eighty":-63.227242,"marketCap":11535737032},{"date":"2026-04-24","current":-44.811176,"twenty":-78.060991,"median":-65.51992,"eighty":-62.332762,"marketCap":11535737032},{"date":"2026-04-30","current":-44.783221,"twenty":-78.021843,"median":-65.28076,"eighty":-60.389723,"marketCap":11535737032},{"date":"2026-05-08","current":-44.644729,"twenty":-77.873074,"median":-65.02482,"eighty":-59.352088,"marketCap":11535737032},{"date":"2026-05-15","current":-44.527613,"twenty":-77.457906,"median":-64.955716,"eighty":-54.162029,"marketCap":11535737032},{"date":"2026-05-22","current":-44.62961,"twenty":-77.130506,"median":-64.865742,"eighty":-48.015114,"marketCap":11535737032},{"date":"2026-05-29","current":-44.474957,"twenty":-77.072723,"median":-64.7737,"eighty":-45.186782,"marketCap":11535737032},{"date":"2026-06-05","current":-44.410504,"twenty":-76.942339,"median":-64.709555,"eighty":-44.836445,"marketCap":11535737032},{"date":"2026-06-12","current":-44.440563,"twenty":-76.790716,"median":-64.652972,"eighty":-44.816847,"marketCap":11535737032},{"date":"2026-06-18","current":-44.334195,"twenty":-76.784092,"median":-64.606806,"eighty":-44.811176,"marketCap":11535737032},{"date":"2026-06-26","current":-44.551763,"twenty":-76.501517,"median":-64.559082,"eighty":-44.783221,"marketCap":11535737032},{"date":"2026-07-03","current":-44.518459,"twenty":-76.499114,"median":-64.484566,"eighty":-44.746029,"marketCap":11535737032},{"date":"2026-07-10","current":-44.573161,"twenty":-76.047687,"median":-64.42138,"eighty":-44.683785,"marketCap":11535737032},{"date":"2026-07-17","current":-44.415099,"twenty":-75.735703,"median":-64.384175,"eighty":-44.631174,"marketCap":11535737032},{"date":"2026-07-24","current":-44.405121,"twenty":-75.569622,"median":-64.258799,"eighty":-44.611538,"marketCap":11535737032},{"date":"2026-07-31","current":-44.320924,"twenty":-75.486659,"median":-64.151322,"eighty":-44.575108,"marketCap":11535737032},{"date":"2026-08-07","current":-44.235034,"twenty":-75.015399,"median":-64.128705,"eighty":-44.551763,"marketCap":11535737032},{"date":"2026-08-14","current":-44.179104,"twenty":-74.694617,"median":-64.015323,"eighty":-44.527613,"marketCap":11535737032},{"date":"2026-08-21","current":-44.081684,"twenty":-74.600848,"median":-63.899985,"eighty":-44.518459,"marketCap":11535737032}],"updateTime":1787452383350},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1151127318","title":"AB&B Bio-Tech-B Maintains Stable Share Capital in June; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1151127318","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151127318?lang=en_us&edition=fundamental","pubTime":"2026-07-06 16:58","pubTimestamp":1783328288,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech-B (02627.HK) submitted its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited on 6 July 2026, covering the month ended 30 June 2026. The filing indicates no...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122304834","title":"AB&B Bio-Tech releases quarterly resumption update, defers 2025 AGM; trading to stay suspended","url":"https://stock-news.laohu8.com/highlight/detail?id=1122304834","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122304834?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:25","pubTimestamp":1782825915,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech CO., LTD. JS (the “Company”) on 30 June 2026 issued a quarterly progress report on its trading resumption plan, announced the postponement of its 2025 annual general meeting (AGM), and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AB&B Bio-Tech releases quarterly resumption update, defers 2025 AGM; trading to stay suspended","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177572709","title":"Hong Kong Market Announcement Highlights: Seer Tech and Micot Pharma Debut Today, Cathay Pacific Reports 17% Passenger Growth in May","url":"https://stock-news.laohu8.com/highlight/detail?id=1177572709","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177572709?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:20","pubTimestamp":1782264026,"startTime":"0","endTime":"0","summary":"Key Corporate Developments:SEER TECH (06106): Its Hong Kong public offering received 5,934.56 times subscription, with net proceeds from the global offering amounting to approximately HK$995.4...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2488822045.USD","VXUS","BK1561","LU2476274720.SGD","02627","02335","IE00BPRC5H50.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU2476274308.USD","BK1161","02256","BK1219","BK1123","02273","IE00B543WZ88.USD","00293","IPOS","06106","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645838478","title":"Ab&B Bio-Tech's Application for Mpox Vaccine Approved in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2645838478","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645838478?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:00","pubTimestamp":1782212407,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech's (HKG:2627) investigational new drug application for its mRNA mpox vaccine candidate was approved by China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.Trading in the company's shares, which was suspended April 1, remains suspended.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121897103","title":"AB&B BIO-TECH-B's mRNA Monkeypox Vaccine Candidate Receives IND Approval from China's CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=1121897103","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121897103?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:12","pubTimestamp":1782209561,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (ASX: 02627) has announced that, following the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA), the Center for Drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","159646","BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645988774","title":"AB&B Bio-Tech wins China CDE IND clearance for mRNA mpox vaccine candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2645988774","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645988774?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:09","pubTimestamp":1782209352,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech secured China CDE IND clearance on June 21, 2026 for its self-developed mRNA mpox vaccine candidate.The candidate previously received U.S. FDA IND clearance, positioning it as the first mRNA mpox program cleared in both markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL2GD248:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645887784","title":"Ab&B Bio Tech Co Js - China Cde Approves Ind Application for Mrna Mpox Vaccine on June 21, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2645887784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645887784?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:08","pubTimestamp":1782209315,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nFWN42V0C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102322899","title":"AB&B Bio-Tech appoints Baker Tilly Aranea and Cheng & Cheng for forensic investigation and internal control review; trading remains suspended","url":"https://stock-news.laohu8.com/highlight/detail?id=1102322899","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102322899?lang=en_us&edition=fundamental","pubTime":"2026-06-05 19:25","pubTimestamp":1780658742,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech CO., LTD. JS (the “Company”) has engaged two independent firms to address resumption guidance issued by the Hong Kong Stock Exchange following its auditor change in April 2026. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AB&B Bio-Tech appoints Baker Tilly Aranea and Cheng & Cheng for forensic investigation and internal control review; trading remains suspended","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641576117","title":"AB&B Bio-Tech hires Baker Tilly unit for forensic probe into fund investments, consultancy payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2641576117","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641576117?lang=en_us&edition=fundamental","pubTime":"2026-06-05 19:21","pubTimestamp":1780658506,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech engaged Baker Tilly Aranea to run a forensic probe into fund investments and consultancy payments tied to its resumption requirements.Cheng & Cheng Risk Advisory Services was appointed to review internal controls covering the same areas.Trading in the company’s H shares has been suspended since April 1, 2026, pending further notice.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDLbh6T1Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199640264","title":"AB&B Bio-Tech Reports No Change in Share Capital for May 2026; Confirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1199640264","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199640264?lang=en_us&edition=fundamental","pubTime":"2026-06-04 17:23","pubTimestamp":1780565017,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech (H shares listed under stock code 02627) released its Monthly Return for Equity Issuer, confirming that total authorised capital and issued share structure remained unchanged in May...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136507632","title":"Ab&B Bio-Tech Updates Board Composition and Committee Assignments","url":"https://stock-news.laohu8.com/highlight/detail?id=1136507632","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136507632?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:03","pubTimestamp":1779883392,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS announced the latest configuration of its Board of Directors and the corresponding committee assignments. The Board now comprises eight members, including three executive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638502035","title":"AB&B Bio-Tech files directors list with Hong Kong stock exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2638502035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638502035?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:42","pubTimestamp":1779882165,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech filed an updated list of directors with the Hong Kong Stock Exchange dated May 27, 2026.An Youcai remains chairman, leading a board comprising three executive directors, two non-executive directors, four independent non-executive directors.Li Jianjun chairs the audit committee, Chen Chengbei chairs remuneration and appraisal, Li Xiangming chairs nomination.An Youcai chairs the strategy committee, with He Yiming and Li Xiangming as members.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 27, 2026, and is solely responsible for the information c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL8KBTTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169058245","title":"AB&B BIO-TECH-B (02627) Appoints Le Meijia as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1169058245","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169058245?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:35","pubTimestamp":1779881745,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) has announced the appointment of Ms. Le Meijia as an Independent Non-Executive Director of the second-term Board of Directors and a member of the Board's Audit Committee,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112879198","title":"AB&B BIO-TECH-B (02627) Commences Phase I/II Trials for Its Adjuvanted RSV Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1112879198","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112879198?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:48","pubTimestamp":1778676509,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced that the group has recently initiated Phase I and Phase II clinical trials for its self-developed adjuvanted recombinant Respiratory Syncytial Virus (RSV) vaccine...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159646","02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635822907","title":"AB&B Bio-Tech wins China NMPA approval for RSV vaccine clinical trial program","url":"https://stock-news.laohu8.com/highlight/detail?id=2635822907","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635822907?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:41","pubTimestamp":1778676088,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech said China NMPA granted clinical trial authorization in August 2025 for its adjuvanted recombinant RSV vaccine made in CHO cells.Phase I and Phase II trials have been initiated.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL9bpbcH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782216","title":"AB&B Bio-Tech starts Phase I/II trials for self-developed recombinant RSV vaccine candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782216","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782216?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:41","pubTimestamp":1778676086,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech launched Phase I and Phase II clinical trials for its self-developed recombinant RSV vaccine using CHO cells with an adjuvant.No clinical results have been presented; trials have just started following China IND clearance received in August 2025.Preclinical work indicated stronger immune response, improved stability, and a safety profile supportive of advancing into human testing, without reporting clinical outcomes.Program positions company in RSV prevention market where limited treatment options keep vaccination central to disease control strategy.H-share trading remains suspended from April 1, 2026 pending further notice.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL6jLvPJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192053390","title":"Ab&B Bio-Tech obtains China CDE IND approval for mRNA RSV vaccine candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1192053390","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192053390?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:03","pubTimestamp":1778245399,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS (Ab&B Bio-Tech) announced that China’s Center for Drug Evaluation (CDE) has cleared the Investigational New Drug (IND) application for the Group’s self-developed messenger...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183165347","title":"AB&B BIO-TECH-B Receives Chinese Regulatory Nod for mRNA RSV Vaccine Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1183165347","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183165347?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245219,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced that, following the U.S. Food and Drug Administration's approval of its Investigational New Drug (IND) application in the United States on November 7, 2025, the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1161","BK4534","BK4585","BK4501","IND","BK4533","BK4551","MRNY","BK4139","MRNA","02627","BK4548","BK4568","BK4532","MRNX","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459787","title":"AB&B Bio-Tech wins China CDE IND approval for self-developed mRNA RSV vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459787","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633459787?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:56","pubTimestamp":1778244989,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech secured China CDE clearance for an investigational new drug filing for its self-developed mRNA RSV vaccine candidate.U.S. FDA had cleared the vaccine’s IND on Nov. 7, 2025.H-share trading remains suspended in Hong Kong since April 1, 2026, pending further notice.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL1wWb2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459246","title":"Ab&B Bio Tech Co Ltd Js - China Cde Approves Ind Application for Ab+B Bio-Tech's Mrna Rsv Vaccine Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633459246?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:56","pubTimestamp":1778244960,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nFWN41L19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":69,"code":"91000000","status":"200"}]}}